• LAST PRICE
    2.2700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.2200/ 50
  • Ask / Lots
    2.3000/ 1
  • Open / Previous Close
    0.0000 / 2.2700
  • Day Range
    ---
  • 52 Week Range
    Low 0.9739
    High 4.3600
  • Volume
    80
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 2.21
TimeVolumeIMRA
09:32 ET9412.18
09:34 ET6002.18
09:36 ET232732.21
09:38 ET14002.2
09:39 ET1002.19
09:41 ET34002.2
09:43 ET12002.2
09:45 ET14002.21
09:48 ET2002.21
09:50 ET2002.225
09:59 ET49492.23
10:01 ET108002.23
10:06 ET142002.25
10:08 ET24112.26
10:10 ET10002.26
10:12 ET3002.26
10:21 ET1002.25
10:26 ET1002.26
10:33 ET80472.25
10:37 ET32302.25
10:39 ET4002.25
10:42 ET34002.25
10:44 ET14002.25
10:46 ET13002.25
10:50 ET24002.23
10:51 ET1002.24
10:55 ET1002.235
10:57 ET3002.24
11:00 ET29962.245
11:04 ET58502.245
11:06 ET29002.24
11:15 ET5002.23
11:18 ET14102.23
11:20 ET314682.24
11:24 ET893782.23
11:26 ET538112.23
11:29 ET1432.24
11:36 ET1002.25
11:42 ET12002.25
11:45 ET5002.26
11:51 ET299892.2865
11:54 ET5832.29
11:56 ET37572.275
12:05 ET16002.27
12:12 ET1002.26
12:23 ET5002.26
12:25 ET19002.27
12:32 ET3002.27
12:34 ET4992.28
12:38 ET2002.27
12:39 ET19002.27
12:41 ET4002.26
12:57 ET59402.27
01:14 ET1002.26
01:28 ET14002.27
01:30 ET4002.26
01:42 ET3002.26
01:46 ET1002.26
01:51 ET1002.277
01:57 ET5002.26
02:00 ET1502.2606
02:02 ET1002.26
02:04 ET2002.2601
02:06 ET26002.26
02:09 ET47002.25
02:11 ET7002.26
02:24 ET4002.26
02:27 ET2002.26
02:36 ET3002.26
02:40 ET27002.25
02:47 ET4002.2427
02:49 ET10002.24
02:54 ET2002.25
02:56 ET5002.25
03:00 ET17722.2501
03:03 ET77502.27
03:07 ET45002.28
03:14 ET2002.285
03:16 ET15972.28
03:18 ET18002.281
03:21 ET4002.28
03:25 ET2002.28
03:30 ET18002.28
03:34 ET185672.27
03:36 ET28002.27
03:39 ET249292.27
03:41 ET116132.26
03:45 ET131002.2689
03:48 ET345502.27
03:50 ET15002.27
03:54 ET24502.27
03:56 ET216292.27
03:57 ET33562.26
03:59 ET104842.27
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMRA
Imara Inc
55.5M
-1.1x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
61.6M
-1.6x
---
United StatesNVNO
enVVeno Medical Corp
55.4M
-2.9x
---
United StatesNCNA
NuCana PLC
52.7M
-1.4x
---
United StatesSNTI
Senti Biosciences Inc
53.4M
-8.0x
---
United StatesCIPI
Correlate Infrastructure Partners Inc
58.0M
-18.2x
---
As of 2022-09-29

Company Information

Imara, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9). PDE9 selectively degrades cyclic guanosine monophosphate (cGMP), an active signaling molecule. IMR-687 is in Phase IIb clinical development for the treatment of sickle cell disease (SCD) and beta- thalassemia. It is also focused on initiating a Phase II clinical trial of IMR-687 in heart failure with preserved ejection fraction (HFpEF). The Company is also focused on development of IMR-261, an oral, clinic-ready activator of nuclear factor erythroid 2-related factor 2 (Nrf2).

Contact Information

Headquarters
116 HUNTINGTON AVENUE, 6TH FLOORBOSTON, MA, United States 02116
Phone
617-206-2020
Fax
302-655-5049

Executives

Independent Chairman of the Board
David Mott
President, Chief Executive Officer, Director
Rahul Ballal
Chief Financial Officer, Chief Operating Officer
Michael Gray
Independent Director
David Bonita
Independent Director
Mark Chin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$55.5M
Revenue (TTM)
$0.00
Shares Outstanding
26.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.08
Book Value
$3.27
P/E Ratio
-1.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.